LINDSEY OSTEEN: Open Payments
NPI 1487138210 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,274 in 55 payments from 21 companies in 2025. Trend: 2023 $649 · 2024 $1,185 · 2025 $1,274
Food & beverage: $1,274
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $209 |
| Regeneron Healthcare Solutions, Inc. | 3 | $140 |
| ABBVIE INC. | 4 | $93 |
| Merck Sharp & Dohme LLC | 4 | $91 |
| Tempus AI, Inc | 3 | $79 |
| Myriad Genetic Laboratories, Inc. | 3 | $74 |
| Incyte Corporation | 3 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $62 |
| Eisai Inc. | 3 | $61 |
| PFIZER INC. | 2 | $56 |
Products named: LIBTAYO, EPKINLY, KEYTRUDA, IMFINZI, XT CDX, MYRISK, Nubeqa, Lenvima.
Industry payments across TX — which companies pay providers there.
